Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Joincare’s Modified Drug XYP-001 Gains NMPA Approval for IPF Trial

February 6, 2025
CompanyDeals

Koutech Robotics Secures Series A Funding for Surgical Innovation

February 6, 2025
CompanyDrug

CARsgen Therapeutics Presents Positive Phase Ib/II Data for CT053 at CAR-TCR Summit

February 6, 2025
CompanyDeals

Joincare Pharmaceuticals Prices GDRs on SIX Swiss Exchange

February 6, 2025
Company

Northeast Pharmaceutical to Invest in Shanghai Subsidiary for ADC and CAR-T Development

February 6, 2025
Policy / Regulatory

Beijing Designates 923 Medical Entities for National Reimbursement Drug List

February 6, 2025
Company

Lee’s Pharmaceutical Reports H1 Revenue Growth Amid Product Portfolio Shift

February 6, 2025
CompanyDrug

Junshi Biosciences’ Tuoyi Approved for First-Line NSCLC Treatment in China

February 6, 2025
CompanyDrug

Sun-Novo’s STC007 Gains NMPA Approval for Postoperative Pain Study

February 6, 2025
CompanyDeals

WuXi Biologics Partners with Elpiscience for Macromolecule Development

February 6, 2025
CompanyDrug

Tasly Pharmaceuticals Gains NMPA Approval for B1344 Diabetes Study

February 6, 2025
CompanyDrug

Clover Biopharmaceuticals Reports Positive Phase III Data for COVID-19 Vaccine SCB-2019

February 6, 2025
1 2 … 6 7 8 9 10 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up